Wednesday, June 26, 2024
- Advertisement -spot_img

TAG

H.I.V

How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy

In 2004, Gilead Sciences determined to prevent pursuing a new H.I.V. drug. The public explanation used to be that it wasn’t sufficiently other from...

Global Push to Treat H.I.V. Leaves Children Behind

The tales the moms inform once they collect on the Awendo Health Centre in western Kenya are a catalog of small failures, missed alternatives...

Latest news

- Advertisement -spot_img